Presentations
News & Events
- December 8, 2017
-
November 6, 2017 - November 7, 2017
Proceedings from Huntington’s Disease Regulatory Science Consortium (HD-RSC) Kick-Off Meeting, Nov. 6-7, 2017
On November 6 and 7, 2017, in Silver Spring, MD, Critical Path Institute and CHDI Foundation welcomed participants from the pharmaceutical industry, academia, regulatory agencies, and advocacy groups to a kick-off meeting for the Huntington’s Disease Regulatory Science Consortium (HD-RSC). The meeting objectives were to solicit input from stakeholders on HD-RSC plans and deliverables, and...... -
November 4, 2017
Evaluating the Conceptual Equivalence Between Paper and Three Electronic Data Collection Modes of the EQ-5D-5L Health Status Instrument
Crescioni M, Flood E, Lundy JJ, Coons SJ, Byrom B, Eremenco S. Evaluating the Conceptual Equivalence Between Paper and Three Electronic Data Collection Modes of the EQ-5D-5L Health Status Instrument. International Society for Pharmacoeconomics and Outcomes Research 20th Annual European Congress; 2017 Nov 4; Glasgow, Scotland.
-
November 4, 2017
Allowing Respondents to Skip Items During Electronic Collection of Patient-Reported Outcome (PRO) Data: Does It Matter?
O’Donohoe P, Eremenco S, Coons SJ, Crescioni M, Arnera V. Allowing Respondents to Skip Items During Electronic Collection of Patient-Reported Outcome (PRO) Data: Does It Matter? International Society for Pharmacoeconomics and Outcomes Research 20th Annual European Congress; 2017 Nov 4; Glasgow, Scotland.
-
November 1, 2017
FDA qualification of intracranial adjusted hippocampal volumetric magnetic resonance imaging (ICV-HV vMRI) as a prognostic biomarker for pre-dementia clinical trials for Alzheimer disease therapeutics
Conrado, D.J., et al.; “FDA qualification of intracranial adjusted hippocampal volumetric magnetic resonance imaging (ICV-HV vMRI) as a prognostic biomarker for pre-dementia clinical trials for Alzheimer disease therapeutics.” 10th Clinical Trials on Alzheimer’s Disease (CTAD), Boston, MA, November 1-4, 2017, The Journal of Prevention of Alzheimer’s Disease 4(4): 345....